Open AccessProstaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD
Author(s) -
Caroline E. Douma,
Dirk R. de Waart,
Désirée Zemel,
Dirk G. Struijk,
R. T. Krediet
Publication year - 2001
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/16.4.803
Subject(s) - medicine , peritoneal dialysis , pharmacology , prostaglandin , prostaglandin e2 , peritoneum , surgery
Prostaglandins can affect the vascular response and are locally produced in the peritoneal cavity. Prostaglandin inhibition in continuous ambulatory peritoneal dialysis (CAPD) patients during peritonitis using indomethacin intraperitoneally was found to decrease the intrinsic permeability to macromolecules.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom